试用视觉搜索
使用图片进行搜索,而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索,请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等(默认)
关闭
筛选器
2040×1148
www.fiercebiotech.com
ResMed's 2024 fiscal year kicks off with plans to lay off 5% of workers
6250×3516
www.fiercebiotech.com
GSK shuffles R&D as research head John Lepore heads out the door
4500×3000
www.fiercebiotech.com
Sage lays off half of R&D team and shakes up C-suite again
6000×3385
www.fiercebiotech.com
Abbott advances clinical studies in pulsed field ablation, collects ...
5904×3321
www.fiercebiotech.com
Shattuck axes CD47 program over weak efficacy data, lays off 40% of ...
5000×2813
www.fiercebiotech.com
Applied Therapeutics fails heart disease phase 3, seeks partner to ...
6000×3375
www.fiercebiotech.com
Kezar halts dosing and enrollment in key lupus study after 4 patient ...
1732×1732
www.fiercebiotech.com
Novo pens $285M biobucks deal to use As…
1370×913
www.fiercebiotech.com
J&J MedTech aims to put Ottava surgical robot up for US clinical trials ...
2121×1414
www.fiercebiotech.com
Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral ...
1904×1075
www.fiercebiotech.com
Horizon Surgical claims $30M for robotic, image-guided cataract surgery
3000×1687
www.fiercebiotech.com
Novartis pens $150M upfront bispecifics deal with Dren Bio
2120×1192
www.fiercebiotech.com
Sarepta axes late-phase DMD drug over safety signal, FDA talks
4442×2500
www.fiercebiotech.com
J&J opens the valve on $50M MS partnership with Pipeline
3840×2160
www.fiercebiotech.com
New EHA data show how Gilead's $4.9B bet on CD47 imploded
3000×1688
www.fiercebiotech.com
FDA approves Medtronic’s rechargeable deep brain stimulator for ...
2120×1414
www.fiercebiotech.com
FDA approves biodegradable metal screw implant for fixing br…
1999×1123
www.fiercebiotech.com
Incyte's $750M buyout rocked by pause on key trial, asset cull
3181×2122
www.fiercebiotech.com
Edwards excites with Evoque FDA approval in transcatheter tricuspi…
2500×1407
www.fiercebiotech.com
Septerna plans $158M IPO to fund readouts for GPCR pipeline
2121×1414
www.fiercebiotech.com
Agenus lays off 25%, sidelines programs to focus on cancer combo
7000×3937
www.fiercebiotech.com
Akero soars as liver scarring improves in longer MASH trial
2000×1125
www.fiercebiotech.com
Exelixis lays off 175 employees in refocus on ‘emerging pipeline’
2500×1407
www.fiercebiotech.com
Valneva pays LimmaTech $10M for Shigella vaccine
2059×1456
www.fiercebiotech.com
CRISPR Therapeutics laid off staff a week after positive adc…
2088×1170
www.fiercebiotech.com
100 days with John Crowley: Behind BIO’s new structure & vision
7424×4176
www.fiercebiotech.com
Dyne shakes up C-suite after hazy DMD data drop
5000×2693
www.fiercebiotech.com
New AI drug discovery powerhouse Xaira rises with $1B in funding
2700×1801
www.fiercebiotech.com
Exact Sciences’ posts positive data for its capsule-on-a-string t…
3000×1688
www.fiercebiotech.com
Merck, flush with ADCs, eyes diversity in massive Daiichi deal
2121×1198
www.fiercebiotech.com
Blackstone, Sutro ink pact worth up to $390M biobucks
3000×1688
www.fiercebiotech.com
2023's top 10 clinical trial flops
2121×1414
www.fiercebiotech.com
Innovent links IL-2 fusion protein to responses in small study
2000×1129
www.fiercebiotech.com
Radiopharma Alpha-9 raises $175M series C to fund clinical push
5209×4167
www.fiercebiotech.com
Patient death prompts Roche to adjust Alzheimer's trial
某些结果已被隐藏,因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
Invisible focusable element for fixing accessibility issue
反馈